Gene therapy education materials for the sickle cell disease community
Understanding gene therapy for sickle cell disease
Sickle cell disease gene therapy education project
Sickle cell disease is the most common inherited blood disorder in the United States, affecting more than 100,000 people.
Overview
Presently, there are only a handful of options to manage or treat sickle cell disease. Â
Now, researchers are developing new and emerging gene therapies to treat sickle cell disease.
To help navigate these new therapies, more than 50 scientists, physicians, patients and other experts worked together to develop content for the Democratizing Education for Sickle Cell Disease Gene Therapy Project, which is led by NHGRI in partnership with other organizations and individuals. This group met over the course of four workshops.
The Democratizing Education Project welcomes your feedback about the sickle cell disease gene therapy resources. Please email your comments or questions to DemocratizingEd@mail.nih.gov.
These educational materials are for informational purposes only. They are meant to promote your general understanding of gene therapy for sickle cell disease. We encourage you to use these educational materials to talk with your healthcare provider or a clinical trial team.
Additional resources
Download PDF
Gene Therapy Education Materials for the Sickle Cell Disease Community
Patient education materials
Last updated: September 22, 2022
Sickle Cell Reproductive Health Education Directive (SC RED) advocates for high quality sexual and reproductive health care for individuals living with all types of sickle cell disease
Receive updates, news and other related topics to your email address